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Abstract
Background: The urokinase receptor (uPAR) mediates a diverse array of cellular processes
including several events involved in prostate cancer metastasis. Many of these activities are initiated
or enhanced by uPAR binding to its proteolytic ligand, urokinase (uPA). Our objective in this study
was to generate and test an inducible lentiviral system capable of expressing uPAR and DsRed
fluorescent protein in human prostate cancer cell lines.
Results: A DsRed-uPAR fusion construct was inserted into a lentiviral vector. Transduction of
human prostate cancer cell lines with this virus and with a virus containing a reverse-tetracycline
transactivator (rt-TA) resulted in a stable transgene which induced both uPAR and DsRed proteins
in a dose-responsive fashion upon stimulation with doxycycline. Immunoblots and
immunofluorescence studies indicated no detectable uPAR expression in non-induced prostate
cancer cell lines. Cells with induced-uPAR demonstrated increased cellular adhesion to the matrix
substrate vitronectin and increased net cell proliferation compared to uninduced cells. Finally,
induced uPAR-expressing prostate cancer cells were resistant to anoikis over an extended time
period when grown in suspension.
Conclusion: This doxycycline-inducible lentivirus system produces titerable levels of biologically
active uPAR in vitro. This tool can be used to dissect cellular events following induction of uPAR in
prostate cancer cells.
Background
The urokinase receptor (uPAR) contributes to a diverse
array of cellular processes such as intravascular homeosta-
sis, inflammation, cancer metastasis, proliferation, activa-
tion of protease cascades, matrix degradation and cell
migration. Many but not all of these activities are initiated
or enhanced by uPAR binding to its proteolytic ligand,
urokinase (uPA) [1,2]. Molecularly, uPAR consists of 3
separate domains forming a bowl which binds uPA within
the central cavity [3]. Recently, a 2.8 Å resolution crystal
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structure of a soluble uPAR fragment was described and
this structure demonstrates that residues within all three
domains participate in uPA binding. This crystal structure
also suggests how uPA binding may induce substantial
conformational changes in uPAR to reposition receptor
subdomains and increase the affinity and specificity of
these subdomains towards pericellular proteins such as
vitronectin, various integrins, low-density lipoprotein
receptor, epidermal growth factor receptor and other
receptors [3].
In vitro and in vivo models to study uPAR biology are
improving and with these models are coming novel iden-
tifications of cellular processes upregulated by uPAR
action. We have recently found that in an in vivo assay of
orthotropic metastasis to regional lymph nodes, metas-
tases which succeed in invading as far as these lymph
nodes and then proliferated within the nodes possessed
significantly greater numbers of uPAR-positive staining
cells when compared to the general population of cells
within the primary tumor [4]. To investigate how
increased uPAR might promote tumor metastasis, we
modeled metastatic transit by placing cells in suspension
culture. Although this suspension normally induces a
form of apoptosis called "anoikis", we found that suspen-
sion resulted in an increase in uPAR cell surface expres-
sion. Using transient transfection, we reported that cells
showing high uPAR appeared more resistant to anoikis
than lower expressing cells [4].
Transfection of uPAR produced high receptor levels in a
relatively low percent prostate cancer cells and thus we
wished to greatly enhance the percentage of uPAR-overex-
pressing cells in follow-up experiments. In addition, the
transient nature of transfected plasmid expression limited
the potential time course of anoikis assays. Therefore we
designed a regulatable approach to control transgene
expression of uPAR utilizing a tetracycline (tet)-inducible
vector. Tetracycline-regulated gene expression is the most
common and well characterized method of controlling
transgene expression. It allows gene induction following
administration of a tetracycline antibiotic such as doxycy-
cline. Binding of doxycycline to a series of tet resistance
operon sequences transactivates a minimal CMV pro-
moter activating gene expression in the presence of antibi-
otic [5,6]. Unfortunately, inducible systems have been
traditionally plagued by weakness of leak-through of
unwanted gene expression or inadequate inducibility [7].
To circumvent these potential problems, we have used a
recently redesigned tet-inducible lentivirus vector system.
This lentivirus vector possesses a chicken β-globin insula-
tor sequence to insulate the minimal promoter from chro-
mosome position effects and a second-generation
tetracycline response element (TRE) with optimized dis-
tance and rotation between tet operator (tetO) sequences.
In addition, many of the U3 proviral long terminal repeat
sequences have been deleted [7].
In this study, we report the development and employment
of this inducible model system to trigger controlled uPAR
induction by treatment with doxycycline. This model has
no detectable leakage of uPAR expression in non-induced
cells and produces the co-expression of the fluorescent
DsRed protein in doxycycline-stimulated cells. We have
employed this lentiviral system in two prostate cancer cell
lines which express low or no detectable uPAR. We show
the dose-responsive induction of both uPAR and DsRed
following doxycycline administration. Using the cells gen-
erated with this lentiviral system, we have assessed a
number of biological responses associated with increased
uPAR such as adhesion to vitronectin and proliferation.
We also used the inducible cells along with controls to fur-
ther substantiate the ability of uPAR to provide significant
resistance to anoikis in these cells lacking of wild-type
uPAR.
Results
A culture variant of the PC-3M cell line expresses no 
detectable uPAR protein
A variant PC-3M cell line which expressed little or no
detectable uPAR when compared with either parental PC-
3M cells or PC-3 cells developed spontaneously in culture
(Figure 1A). We selected this cell variant (which we
named "PC-3M-CBS") and the LNCaP prostate cancer line
to study the effect of inducing uPAR against a background
of little or no endogenous protein expression.
Doxycycline induces uPAR and DsRed protein expression 
in a dose-responsive pattern in two prostate cancer cell 
lines
PC-3M-CBS and LNCaP cells were transduced with an
inducible lentiviral construct bearing a DsRed-uPAR
cDNA fusion. Since uPAR is post-translationally processed
by removal of amino acids from both the amino and car-
boxy terminals, uPAR and DsRed proteins are expressed
separately and therefore migrate according to their true
molecular mass. In PC-3M-CBS cells, doxycycline induced
robust uPAR expression at 0.1 ug/mL, this expression
increased with greater levels of doxycycline and appeared
to reach a plateau at 1.0 ug/mL (Figure 2). No uPAR signal
appeared in either the uninduced, wild-type or DsRed
expressing cells when loaded at 50 ug total protein per
electrophoresis lane. DsRed protein in these cells also
increased in a dose-responsive fashion after doxycycline
stimulation but appreciable levels of DsRed monomer
appeared only after 0.5 ug/mL treatment. The slight vari-
ance between observed uPAR and DsRed protein levels in
these immunoblots may reflect differences in the half-
lives of uPAR and DsRed monomer in these cells. DsRed
protein appeared as two bands with the more prominentMolecular Cancer 2007, 6:34 http://www.molecular-cancer.com/content/6/1/34
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band being a higher molecular weight. These two bands
likely indicate that there are at least two sites of post-trans-
lational cleavage of DsRed from uPAR.
LNCaP prostate cancer cells were also transduced with the
inducible lentiviral vector. These cells also showed a dose-
response to doxycycline stimulation with regard to uPAR
induction; however a 0.5 ug/mL concentration was
required to induce high levels of protein expression. In
these cells, the uPAR signal also appeared to plateau at the
1.0 ug/mL concentration. DsRed expression was increased
by increasing doxycycline in the LNCaP line and again,
the monomer appeared in two distinct bands. Because
these results indicated that uPAR expression was maximal
after 1.0 ug/mL doxycycline and because this level of stim-
ulation also produced substantial levels of DsRed mono-
mer, we used 1.0 ug/mL doxycycline throughout
subsequent experiments.
Immunoreactive expression of uPAR and fluorescence
from DsRed protein followed stimulation with 1.0 ug/mL
doxycycline. These induced cells displayed pronounced
levels of both proteins compared with uninduced cells
(Figure 3). Post-translational cleavage of DsRed from
uPAR results in separate proteins and in these images,
DsRed protein is distributed cytoplasmically while uPAR
is seen at the cell surface. A representative flow cytometry
scatter plot shows the shift in fluorescence after overall
induction of both proteins in the cell population (Figure
4).
uPAR induction or supplemental uPA addition promote 
increased proliferation in PC-3M-CBS and LNCaP cells
We have previously found that uPA can stimulate growth
of prostate cancer cells over a range of concentrations and
that maximal growth stimulation in a cell line which
expresses relatively high levels of uPAR, occurred at 100
pM [8]. To understand the potential effect of uPA on pro-
liferation in uPAR-inducible cells, we therefore added 100
pM uPA to doxycycline-induced or uninduced cultures
and measured increases in cell number over a 6-day
period. DsRed expressing cell lines were used for compar-
ison to ascertain the effect of DsRed expression on growth
rate. In PC-3M-CBS cultures, this experiment revealed that
uPAR induction without addition of uPA promoted an
approximately 2-fold increase in proliferation compared
with uninduced cells or DsRed controls without added
uPA (Figure 5A). However, addition of uPA to uPAR-
induced cells further stimulated growth. uPA addition to
either DsRed controls or uninduced cells did not alter
growth.
Uninduced LNCaP cells treated with uPA grew equiva-
lently to uninduced cells without uPA and to DsRed con-
trol cells with or with out uPA indicating that uPA did not
effect proliferation in this cell line (Figure 5B). These
results are consistent with the documented lack of uPAR
in the LNCaP cell line [9]. When uPAR was induced with
doxycycline however, growth was increased. Addition of
uPA further increased LNCaP growth during the 6 day
period. These results indicate that induced expression of
the uPAR-DsRed fusion is functional and can couple with
existing signal transduction machinery to allow uPA-
mediated proliferation.
uPAR expression enhances cellular adhesion to vitronectin
Wild-type and DsRed-expressing control cells from both
PC-3M-CBS and LNCaP adhered to a vitronectin-coated
surface in equivalent numbers as compared to the respec-
tive cells which were transduced with uPAR-DsRed but
were un-induced (Figure 6). The LNCaP line had much
weaker constitutive adhesion to the vitronectin surface.
Doxycycline induction of uPAR in both prostate cancer
cell lines however, lead to a pronounced increase in the
Upper panel shows expression of endogenous uPAR protein  expression in three PC-3 derived human prostate cancer cell  lines Figure 1
Upper panel shows expression of endogenous uPAR protein 
expression in three PC-3 derived human prostate cancer cell 
lines. Lower panel shows β-actin loading control. 1-PC-3M 
cells; 2-PC-3 cells, 3-PC-3M-CBS cells.Molecular Cancer 2007, 6:34 http://www.molecular-cancer.com/content/6/1/34
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level of attachment indicating that induced uPAR is bio-
logically functional in mediating vitronectin matrix adhe-
sion.
uPAR induction provided substantial resistance to anoikis
To model the state of detachment in which cancer cells
must exist during metastasis, both cancer cell lines were
placed in forced suspension culture and incubated in sus-
pension over a period of days during which the numbers
of early apoptotic vs. live cells were quantitatively scored.
This experiment demonstrated that cells with induced
uPAR were significantly more resistant to developing
anoikis during this long term incubation in suspension
(Figure 7). This anoikis resistance was more dramatic in
the LNCaP line than in the PC-3M-CBS cells. In LNCaP
cells, uninduced, wild-type or DsRed control cells reached
90% annexin positive staining at 5 days, a level more than
3-fold greater than uPAR-induced LNCaP cells. Compared
with uninduced PC-3M-CBS cells, the greater apoptotic
levels in uninduced LNCaP likely reflect greater general
sensitivity towards anoikis.
Discussion
In this study, we describe the construction of an inducible
system to model uPAR overexpression in prostate cancer
cells. The use of lentivirus as a vector system allowed for
straightforward transduction of a relatively high percent-
age of cells with integrated DNA resulting in sustained
DsRed-uPAR transgene. The DsRed fluorescent marker
allowed us to use cell sorting to further purify the popula-
tion of cells capable of inducing transgene expression. In
both cell lines transduced with the inducible uPAR virus,
doxycycline stimulated substantial and dose-dependent
uPAR and DsRed expression, while uninduced cells exhib-
ited no leak-through of transgene expression. The induced
uPAR was biologically active as demonstrated by mod-
estly increased proliferation and markedly increased
adhesion to vitronectin and resistance to anoikis. Since
epithelial cancers have a high mortality within the circula-
tion [10] due in large measure to apoptosis induced by
matrix detachment, uPAR induction might help ensure
survival during hematogenous or lymphatic metastasis
stages.
Induction of uPAR and DsRed protein expression in human prostate cancer cells Figure 2
Induction of uPAR and DsRed protein expression in human prostate cancer cells. Fifty micrograms of protein lysate was 
applied to each lane. Upper panels shows uPAR expression in wild-type PC-3M-CBS and LNCaP cells (Wt.) and in cells trans-
duced with DsRed virus (DsCo; as a control for potential effects due to DsRed expression), relative to levels in cells express-
ing doxycycline-inducible uPAR. uPAR-DsRed was induced in these cells by stimulation with doxycycline HCL at the indicated 
concentrations for 4 days prior to lysis and immunoblot. Middle panel shows DsRed monomer expression in wild-type, DsRed 
control and doxycycline-induced cells. Lower panel shows beta-actin expression as a control for loading.Molecular Cancer 2007, 6:34 http://www.molecular-cancer.com/content/6/1/34
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Most previous evidence of uPAR's role in preventing
apoptosis have relied upon experimentally reduced uPAR
using techniques such as RNAi [11-13] rather than over-
expression of the uPAR protein. Using the RNAi tech-
nique, Alfano et al [11] recently inferred a role for uPAR
in anoikis by reporting knock-down of uPAR increased
anoikis in nontransformed retinal epithelial cells. We
directly demonstrated that increasing uPAR can confer
resistance to anoikis in cancer cells using transient over-
expression [4]. This present report demonstrates that
inducement of stable uPAR results in anoikis resistance
that is long lasting and extends to the LNCaP cell line; a
cell line normally devoid of uPAR as well as to a PC-3M
variant with little or no constitutive uPAR protein expres-
sion.
How uPAR promotes survival in suspension remains to be
deciphered. This receptor has numerous reported associa-
tions with extracellular molecules [2]. uPAR could interact
with these molecules to different degrees according to the
environmental context of the cancer cell. For example,
uPAR linkage with a transmembrane cell-surface receptor
could increase during suspension. Extracellular matrix
adhesion on the other hand might shift the balance of
uPAR associations towards vitronectin and/or integrin
binding. In this regard, the absence of association with
matrix components and resulting loss of uPAR-matrix sig-
naling might be as important to uPAR-induced resistance
to anoikis as the presence of matrix components are to
adhesion.
Conclusion
Since the activities of uPAR play a critical role in several
aspects of tumor progression and particularly in metasta-
sis, inhibitors of uPAR which effectively restore anoikis
may be of potential therapeutics benefit. Although no
experimental therapies have yet attempted to target
anoikis, more generalized inhibition of uPAR expression
and/or activity in experimental mouse prostate cancer
models have been shown to reduce occult metastasis [14],
experimental bone metastasis [15], and cancer cell sur-
vival [9]. With models such as this inducible system, in
vivo  studies may now be designed to understand how
upregulation of uPAR promotes discreet stages of metasta-
sis. This information in turn may facilitate development
of uPAR inhibitors that target specific roles of uPAR dur-
ing metastasis as well as further define the role of this
receptor in metastasis biology.
Methods
Cell culture
PC3M cells (a gracious gift from Dr. Isiah Fidler, MD
Anderson Cancer Center, Houston TX) were maintained
in Minimal Essential Medium with Earle's salts (MEM),
supplemented with 10% fetal bovine serum, 100 units/
mL penicillin, 100 μg/ml streptomycin, and 2.0 mM L-
glutamine. A variant of the PC-3M line expressing low
uPAR spontaneously arouse after serial passaging of the
PC-3M; this variant is named PC-3M-CBS. We used PC-
3M-CBS cells in this study. LNCaP cells were obtained
from the American Type Culture Collection and main-
tained in RPMI medium (phenol-red free) supplemented
Flow cytometry of uPAR cell surface expression and DsRed  fluorescence Figure 4
Flow cytometry of uPAR cell surface expression and DsRed 
fluorescence. Representative scatter plot of uPAR immuno-
fluorescence (x-axis) and DsRed fluorescence (y-axis) by len-
tivirus-transduced PC-3M-CBS cells. Left panel shows fluo-
rescence scatter in uninduced cells; right panel shows 
fluorescence scatter in doxycycline-induced cells. uPAR was 
detected with AlexaFluor 488 secondary goat anti-mouse 
antibody.
uPAR and DsRed expression in prostate cancer cells (200 ×  images) Figure 3
uPAR and DsRed expression in prostate cancer cells (200 × 
images). PC-3M-CBS cells containing uPAR-DsRed lentivirus 
were induced with doxycycline over a 4-day period. The 
overlay image (a) shows expression of both uPAR (green flu-
orescence) and DsRed. Uninduced cells (b) show no fluores-
cence. Phase contrast image (c) of uninduced cells depict 
cells present in (b). LNCaP cells transduced with the lentivi-
rus show a similar positive (d) and negative expression pat-
terns (e & f).Molecular Cancer 2007, 6:34 http://www.molecular-cancer.com/content/6/1/34
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with 10% fetal bovine serum, 100 units/mL penicillin and
100 μg/ml streptomycin sulfate. It was necessary to plate
LNCaP cells on a poly-lysine surface during and after viral
transduction to prevent high levels of cell detachment
associated with transduction.
Plasmids constructs and transduction
The 1.0 kb coding region of human uPAR was amplified
using PCR from a pT7TSuPAR plasmid (a gift from Dr. K.
Karico, U. Pennsylvania [16]) then cloned downstream
from the carboxyl terminus of the DsRed monomer cod-
ing sequence in pDsRed-monomer-C1 vector (BD Bio-
sciences). The inducible DsRed uPAR viral plasmid was
constructed by cloning the DsRed-uPAR fusion cDNA into
the pNL-TRE Pitt-EGFPΔU3 plasmid in place of EGFP [7]
to generate pNL-TRE Pitt-DsRed-uPAR ΔU3. Virus was
generated by transfecting 293 T cells with pNL-TRE Pitt-
DsRed-uPAR  ΔU3 plus pBHAΔΔΔ viral helper plasmid
and pLTRVSVG viral envelop protein plasmid in a ratio of
3 parts DsRed-uPAR transgene, 2 parts helper and 1 part
envelop. The calcium phosphate precipitation was used.
Supernatant virus from 293T conditioned media was col-
lected, filtered through 0.2 um membrane and concen-
trated by ultracentrifugation. This concentrated NL-TRE
Pitt-DsRed-uPAR ΔU3 viral stock was then used to trans-
duce prostate cancer cells.
PC-3M-CBS and LNCaP cells were transduced using both
NL-TRE Pitt-DsRed-uPAR ΔU3 and NL-rtTA-M2 virus to
create an inducible lentiviral delivered system. To induce
expression of the DsRed-uPAR fusion, cells were stimu-
lated with doxycycline HCL.
To control for any effects related to DsRed expression, a
control DsRed-only virus was generated by cloning the
DsRed coding sequence into the viral plasmid pNL-EGFP/
CMV-WPRE(delta3) in place of the EGFP gene. The virus
generated by this plasmid (NL-DsRed control/CMV-
Effect of induced uPAR expression on adhesion to vitronec- tin Figure 6
Effect of induced uPAR expression on adhesion to vitronec-
tin. Adhesion of prostate cancer cells to vitronectin is 
increased by induction of uPAR by doxycycline. Prostate can-
cer cells from wild-type control cultures (grey bars), DsRed-
expressing controls (striped bars), un-induced cultures 
(white bars) and uPAR-induced cells (black bars) were plated 
into vitronectin-coated wells in a 24-well plate. Following a 
one-hour period of attachment, the cells were detached and 
counted as described in Methods. Data is expressed as the 
number of adherent cells per well; error bars show the SD 
from quadruplicate wells.
Effect of induced uPAR expression on proliferation Figure 5
Effect of induced uPAR expression on proliferation. Prostate 
cancer cells were either uninduced or induced to express 
uPAR-DsRed with 1.0 ug/mL doxycycline. DsRed-expressing 
cells were used as a growth control. Cells were plated at 
10,000 cells per well in 24-well plates and grown in culture 
medium containing 2% fetal bovine serum with (+) or with-
out urokinase (uPA; 100 pM). Medium was changed during 
the third day. Symbols and indicated conditions are:  unin-
duced, without uPA; × uninduced plus uPA;  doxycycline 
induced without uPA; ■ doxycycline induced plus uPA;  
DsRed control without uPA; ● DsRed control plus uPA. 
Data reflects the means of 4 wells. Bars, SE.Molecular Cancer 2007, 6:34 http://www.molecular-cancer.com/content/6/1/34
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WPRE(delta3) produces constitutive DsRed expression in
transduced cells.
Western Blotting
Western Blot analysis for uPAR has been previously
described [8]. Antibodies used for experiments in this
study were: mouse anti-human uPAR (MAB 807) from
R&D Systems, rabbit anti-DsRed (6224499) from Clon-
tech and mouse anti-human beta actin (ab4321) AbCam
antibodies.
Immunofluorescence
Cells were fixed and permeabilized for immunofluores-
cence as we have described previously [4]. To detect uPAR,
a primary antibody (anti-uPAR monoclonal, R&D Sys-
tems MAB 807) was then applied to cells for 1.5 hours fol-
lowed by addition of AlexaFluor 488-tagged secondary
antibody (Molecular Probes Inc.). Epifluorescence was
imaged through a Zeiss Axiovert 200 fluorescent micro-
scope and recorded through a Q-Imaging Retiga 2000R
digital camera. Because uninduced cells expressed little or
no fluorescence, phase contrast images of cells in the field
of view were also captured to demonstrate relative posi-
tion and number of these cells.
Flow cytometry
Prostate cancer cells from viral-transduced adherent cul-
tures were left uninduced or were induced with doxycy-
cline for 4 days and then stained for uPAR as described
[4]. Cells were next fixed in 1.0% paraformaldahyde/2.0%
goat serum in PBS and analyzed by flow cytometry for
both DsRed and uPAR expression.
Proliferation assay
Cancer cells were seeded at 10,000 cells per well into 24
well plates and allowed to attach overnight. Human
recombinant urokinase (100 ng/ml) was added to treat-
ment wells in stock medium but with reduced levels of
fetal bovine serum (2%). Quadruplicate wells were
counted per condition on days 2, 4 and 6 of growth using
a hemocytometer.
Vitronectin adhesion assay
Twenty-four well tissue culture plates were coated over-
night with 3.0 ug/well of human vitronectin (purchased
from Sigma Chemicals). The coated wells were washed
twice with PBS then blocked with 1 ml of 1% BSA in PBS
for 1 hour at 37°C. Following a second PBS wash, 1.5 ×
105 PC-3M-CBS and LNCaP cells suspended in stock cul-
ture medium plus 100 pM uPA were seeded onto the
matrices or into BSA only-blocked wells (for a background
measurement) for 1 hour at 37°C. Non-adherent cells
were removed by aspiration and all wells were then
washed twice with PBS. Cells adhering to the vitronectin
surface were removed by trypsinization and counted.
Results are the mean and standard deviation of 4 wells for
each cell line.
Assay to determine anoikis
To initiate apoptosis as a result of detachment (anoikis),
doxycycline-induced, uninduced, DsRed-expressing con-
trols and wild-type cells were removed from culture sur-
faces with 0.4% EDTA in PBS, washed to remove EDTA
and resuspended in growth medium supplemented with
heat-inactivated FBS to a final concentration of 500,000
cells in 5.0 mL. This cell suspension was placed in a 50-mL
polypropylene conical tube coated with poly-HEMA (poly
(2-hydroxyethyl methacrylate; (Sigma-Aldrich chemicals)
to prevent re-attachment [17,18]. Aliquots of the cell sus-
Quantitation of Anoikis Figure 7
Quantitation of Anoikis. The percentage of apoptosis in sus-
pended cells (anoikis) was quantitated over time. Apoptosis 
was calculated from cells which stained positively for annexin 
V. Live cells were calculated as those which stained positively 
for Calcein blue methoxyester and did not stain with annexin 
V. Symbols and indicated conditions are: ❍ Wild-type cells; 
 DsRed control cells;  uninduced cells containing uPAR-
DsRed virus; ▲ doxycycline-induced cells containing uPAR-
DsRed virus. Data represent mean ± S.D. of nine regions 
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pension were analyzed each day to determine an overall
percentage of anoikis for each cell condition.
To quantitate numbers of prostate cancer cells which
became committed to apoptotic pathways, cell suspen-
sions were stained using two dyes: Calcein Blue AM
(Molecular Probes) and Annexin V-Alexa 488 (Molecular
Probes) for 2 hours at 37°C. The Calcein dye is an esteri-
fied probe identifying live cells as it penetrates live cells
and is then hydrolyzed freeing the fluorescent Calcein
blue (excitation peak 373 nm, emission peak 440 nm).
Annexin V staining identifies an early stage during the
apoptotic process as it binds to phosphatidylserine resi-
dues inverted on the plasma membrane. Cell samples
were then viewed using epifluorescence and 9 fields were
scored as either 1) apoptotic (green fluorescence) or non-
apoptotic (blue and not green). Anoikis measurements
were carried out for 6 days in PC-3M-CBS cells while
measurements were halted after 5 days in LNCaP cells
because wild-type, DsRed control and uninduced apop-
totic levels reached approximately 90%.
Abbreviations
uPAR urokinase receptor
uPA urokinase-type plasminogen activator enzyme
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